News Focus
News Focus
icon url

BlazingStocks

04/13/23 3:01 PM

#2023 RE: ProfitScout #2015

Absolutely agree, CURE Pharmaceutical reported Third Quarter 2022 Results with strong sequential and year over year revenue increases and continued high margins...expecting more of the same from the Fiscal Year Financials and Q1.

$CURR